FLT3-TKD Mutation
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Non-interventional Ambispective Real-world Cohort of rEfractory and reLapsed (R/R) FLT3 Mutated Acute MyEloid Leukemia (AML) Patients Treated With Gilteritinib in FrANCE (NCT05193448) | French Innovative Leukemia Organisation | 2021-07-05 |
| Italian Non-Interventional Study of FLT3 Mutated AML Patients (NCT03547258) | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | 2018-07-18 |
| Individual Patient Compassionate Use of Crenolanib (NCT03620318) | Arog Pharmaceuticals, Inc. |
Track FLT3-TKD Mutation automatically
Every clearance here is in the API, with alerts when new ones post.